Pregnancy Clinical Trial
Official title:
Development of a Nationally Scalable Model of Group Prenatal Care to Improve Birth Outcomes: "Expect With Me"
NCT number | NCT02169024 |
Other study ID # | 1304011772 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | February 2014 |
Est. completion date | December 2017 |
Verified date | May 2020 |
Source | Yale University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study addresses the intractable challenges of adverse birth outcomes, including preterm
delivery and low birthweight, by proposing the development, implementation and evaluation of
a model of group prenatal care that could be scaled nationally. Group prenatal care models
have been demonstrated through rigorous research to provide significantly improved birth
outcomes with implications for maternal-child health and substantial cost savings. However,
group prenatal care is currently available to only a small fraction of the more than four
million women who give birth annually in the US. Through the development, implementation and
evaluation of a new model of group prenatal care, we will create an outcomes-focused model of
group prenatal care that will be scalable nationally with an eye toward improving US birth
outcomes.
The long-term objective of the proposed study is to reduce the risk for adverse perinatal
outcomes during and after pregnancy among women and families receiving prenatal care in
health centers in 3 geographic locations serving vulnerable populations: Hidalgo County
Texas, Nashville Tennessee, and Detroit Michigan. We will develop, disseminate, and evaluate
a new and improved model of group prenatal care, "Expect with Me," based on our previous
research on group models of prenatal care, which has already yielded favorable behavioral and
biological results in two randomized controlled trials.
We hypothesize that, relative to women who receive standard individual prenatal care, the
women who receive "Expect with Me" group prenatal care will be significantly more likely to:
1. have better perinatal outcomes, including better health behaviors during pregnancy
(e.g., nutrition, physical activity), better birth outcomes (e.g., decreased preterm
labor, low birthweight, Neonatal Intensive Care Unit stays), and better postpartum
indicators (e.g., increased breastfeeding);
2. report greater change in risk-related behaviors and psychosocial characteristics that
could be considered potential mechanisms for the program's effectiveness;
3. have lower rates of sexually transmitted diseases and rapid repeat pregnancy one year
postpartum;
4. have lower healthcare costs through improved outcomes (e.g., appropriate care
utilization, fewer complications, reduced NICU admissions/length of stays)
Comparisons based on propensity-score matched sample of women receiving standard individual
prenatal care at the same clinical sites.
Status | Completed |
Enrollment | 2402 |
Est. completion date | December 2017 |
Est. primary completion date | December 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - less than 24 weeks pregnant - able to attend groups conducted in English or Spanish - consent to share their data with the study Exclusion Criteria: - severe medical problem requiring individual care only, as determined by the participating clinical practice |
Country | Name | City | State |
---|---|---|---|
United States | Wayne State University | Detroit | Michigan |
United States | Vanderbilt University Medical Center | Nashville | Tennessee |
Lead Sponsor | Collaborator |
---|---|
Yale University | United Health Foundation |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | nurse visitation | participation in a nurse visitation program | 2nd and 3rd trimester of pregnancy | |
Other | sexual debut | age at first intercourse | 2nd trimester pregnancy | |
Other | living situation | where and with whom they live with and the stability of their housing | 2nd and 3rd trimester and 6 and 12 months postpartum | |
Other | transfer of motivation | relation of motivation for self and baby's health | 2nd and3rd trimester and 6 and 12 months postpartum | |
Other | confidence in parenting skills | confidence in parenting skills | 6 and 12 months postpartum | |
Other | intimate partner violence | perpetration and victimization of violence by an intimate partner | measured at 2nd and 3rd trimester and 6 and 12 months postpartum | |
Other | perceived stress | stress level as reported by patient | 2nd and 3rd trimester and 6 and 12 months postpartum | |
Other | depressive symptomatology | patient endorsement of depressive symptoms | 2nd and 3rd trimester of pregnancy | |
Other | perceived discrimination | patient experiences of discrimination | 2nd and 3rd trimester of pregnancy and 6 and 12 months postpartum | |
Other | resilience | shift and persist scale | 2nd and 3rd trimester of pregnancy and 6 and 12 months postpartum | |
Primary | Risk of preterm birth incidence | Incidence risk of delivery before 37 weeks gestation | up to 37 weeks gestation | |
Primary | Risk of low birth weight incidence | Incidence risk of infant weight at birth < 2500 grams | delivery | |
Primary | Risk of small for gestational age incidence | Incidence risk of infant weight below the 10th percentile for the gestational age at birth | delivery | |
Primary | Risk of neonatal intensive care unit (NICU) admission incidence | Incidence risk of being admitted to the neonatal intensive care unit (NICU) at birth | birth | |
Secondary | breastfeeding | initiation and duration of breastfeeding | 6 and 12 months postpartum | |
Secondary | nutrition | nutritional choices, food security, and use of mindful eating practices | 2nd and 3rd trimester of pregnancy and 6 and 12 months postpartum | |
Secondary | physical activity | level of physical activity in a typical week | 2nd and 3rd trimester and 6 and 12 months postpartum | |
Secondary | readiness for labor and delivery | readiness for labor and delivery | measured at 2nd and third trimester | |
Secondary | readiness for taking care of baby | readiness for taking care of baby | 2nd and 3rd trimester of pregnancy | |
Secondary | social support | multidimensional scale of perceived social support subscale | 2nd and 3rd trimester and 6 and 12 months postpartum | |
Secondary | condom use self-efficacy | condom use self efficacy scale | 2nd and 3rd trimester and 6 and 12 months postpartum | |
Secondary | substance use | use of cigarettes, alcohol, and drugs | 2nd and 3rd trimester and 6 and 12 months postpartum | |
Secondary | care satisfaction | satisfaction with Expect With Me group prenatal care and use of program components | 3rd trimester | |
Secondary | adherence to medical recommendations | adherence to medical recommendations (e.g., 6-week postpartum check, pediatric visits, vaccinations, infant feeding) | 6 & 12 months postpartum | |
Secondary | postpartum body mass index | individual's body weight divided by the square of their height (kg/m2) | measured at 6 and 12 months postpartum | |
Secondary | maternal weight gain | weight gain as compared to medical recommendations | measured at 2nd and 3rd trimester and birth | |
Secondary | mode of delivery | mode of delivery (e.g., cesarean, vaginal) | delivery | |
Secondary | sexual risk: condom use | condom use percent (0-100%) | measured at 2nd and 3rd trimester and 6 and 12 months postpartum | |
Secondary | sexual risk: contraceptive use (LARC) | use of other contraceptives to prevent pregnancy (no/yes) | measured at 2nd and 3rd trimester and 6 and 12 months postpartum | |
Secondary | sexual risk: number of sexual partners | number of partners | measured at 2nd and 3rd trimester and 6 and 12 months postpartum | |
Secondary | sexual risk: sexually transmitted infection | sexually transmitted infection (no/yes, during pregnancy or incident postpartum) | measured at 2nd and 3rd trimester and 6 and 12 months postpartum |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Completed |
NCT02566005 -
A Randomized Comparison of Transcervical Foley Bulb With Vaginal Misoprostol to Vaginal Misoprostol Alone for Induction of Labor
|
N/A |